Afuco™ Anti-IAV HA ADCC Therapeutic Antibody (Gedivumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Influenza A virus hemagglutinin HA. Gedivumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection.
Supplier Creative Biolabs
Product # AFC-TAB-027ML
Pricing Inquiry
Host Human
Target IAV HA
Species Reactivity Influenza A virus
Type ADCC enhanced antibody
Applications ELISA, IHC, FC, IP, IF, FuncS
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback